Literature DB >> 21666454

Murine models in critical care research.

Philippe Haouzi1.   

Abstract

INTRODUCTION: Access to genetically engineered mice has opened many new opportunities to address questions relevant to the pathophysiology and treatment of patients in critical conditions. However, the results of studies in mice cannot disregard the unique ability of small rodents to adjust their temperature and high metabolic rate and the corresponding respiratory and circulatory requirements in response to hypoxia. POINT OF VIEW: Studies performed in mice on questions related to metabolic, circulatory, and respiratory regulation should always be considered in light of the ability of mice to rapidly drop their nonshivering thermogenesis-related metabolism. As an example, it has been recently argued that a moderate level of inhaled hydrogen sulfide may have a potential benefit in patients in coma or shock or during an anoxic or ischemic insult, as this toxic gas dramatically reduces the metabolic rate in resting mice. However, acute hypometabolism has long been described in small mammals in response to hypoxia and is not specific to hydrogen sulfide. More importantly, mice have a specific metabolic rate that is 15-20 times higher than the specific metabolic level of a resting human. This difference can be accounted for by the large amount of heat produced by mice through nonshivering thermogenesis, related to the activity of uncoupling proteins. This mechanism, which is essential for maintaining homeothermia in small mammals, is virtually absent in larger animals, including in adult humans. Accordingly, no direct metabolic effect of hydrogen sulfide is observed in large mammals. We present the view that similar reasoning should be applied when the circulatory or respiratory response to hypoxic exposure is considered. This leads us to question whether a similar strategy could occur in mice in critical conditions other than hypoxia, such as in hypovolemic, septic, or cardiogenic shock.
CONCLUSION: Mouse models developed to understand the mechanisms of protection against hypoxia or ischemia or to propose new therapeutic approaches applicable in critical care patients should be understood in light of the specificity of the metabolic, respiratory, and circulatory responses of mice to a hypoxic insult, since many of these adaptations have no clear equivalent in humans.

Entities:  

Mesh:

Year:  2011        PMID: 21666454     DOI: 10.1097/CCM.0b013e3182227550

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  10 in total

Review 1.  Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.

Authors:  Katalin Módis; Eelke M Bos; Enrico Calzia; Harry van Goor; Ciro Coletta; Andreas Papapetropoulos; Mark R Hellmich; Peter Radermacher; Frédéric Bouillaud; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

2.  Respiratory effects of low and high doses of fentanyl in control and β-arrestin 2-deficient mice.

Authors:  Philippe Haouzi; Marissa McCann; Nicole Tubbs
Journal:  J Neurophysiol       Date:  2021-03-03       Impact factor: 2.714

Review 3.  Is pharmacological, H₂S-induced 'suspended animation' feasible in the ICU?

Authors:  Pierre Asfar; Enrico Calzia; Peter Radermacher
Journal:  Crit Care       Date:  2014-03-18       Impact factor: 9.097

4.  Immediate and Long-Term Outcome of Acute H2S Intoxication Induced Coma in Unanesthetized Rats: Effects of Methylene Blue.

Authors:  Takashi Sonobe; Bruno Chenuel; Timothy K Cooper; Philippe Haouzi
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

5.  Alterations of blood chemistry, hepatic and renal function, and blood cytometry in acrylamide-treated rats.

Authors:  Eduardo Rivadeneyra-Domínguez; Yesenia Becerra-Contreras; Alma Vázquez-Luna; Rafaél Díaz-Sobac; Juan Francisco Rodríguez-Landa
Journal:  Toxicol Rep       Date:  2018-11-06

6.  A combined antitumor strategy of separately transduced mesenchymal stem cells with soluble TRAIL and IFNβ produces a synergistic activity in the reduction of lymphoma and mice survival enlargement.

Authors:  Adriana G Quiroz-Reyes; Carlos A González-Villarreal; Herminia Martínez-Rodriguez; Salvador Said-Fernández; Mario César Salinas-Carmona; Alberto Y Limón-Flores; Adolfo Soto-Domínguez; Gerardo Padilla-Rivas; Roberto Montes De Oca-Luna; Jose F Islas; Elsa N Garza-Treviño
Journal:  Mol Med Rep       Date:  2022-04-29       Impact factor: 3.423

7.  Tissue hypoxia during acute hemorrhage.

Authors:  Philippe Haouzi
Journal:  Crit Care       Date:  2013-03-28       Impact factor: 9.097

Review 8.  The ethical dimension in published animal research in critical care: the public face of science.

Authors:  Meredith Bara; Ari R Joffe
Journal:  Crit Care       Date:  2014-01-14       Impact factor: 9.097

9.  A mouse is not a rat is not a man: species-specific metabolic responses to sepsis - a nail in the coffin of murine models for critical care research?

Authors:  Peter Radermacher; Philippe Haouzi
Journal:  Intensive Care Med Exp       Date:  2013-10-29

10.  The metabolic phenotype of rodent sepsis: cause for concern?

Authors:  Parjam S Zolfaghari; Bernardo Bollen Pinto; Alex Dyson; Mervyn Singer
Journal:  Intensive Care Med Exp       Date:  2013-10-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.